Furthermore, PSGL-1 possesses broad-spectrum antiviral activity (against e.g., HIV-1, murine leukemia virus, and influenza A virus) (95), by blocking viral infections through steric hindrance of particle attachment to target cells. This evidence concerns the gene SELPLG and viral infectious disease.